Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

carbendazim

A broad-spectrum benzimidazole antifungal with potential antimitotic and antineoplastic activities. Although the exact mechanism of action is unclear, carbendazim appears to binds to an unspecified site on tubulin and suppresses microtubule assembly dynamic. This results in cell cycle arrest at the G2/M phase and an induction of apoptosis.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:carbendazole
Foreign brand name:Bavistin
Derosal
Abbreviation:BCM
BMC
MBC
Code name:BAS-3460
BAS-67054
CTR-6669
FB642
HOE-17411
Chemical structure:1H-benzimidazol-2-ylcarbamic acid methyl ester
2-(methoxycarbonylamino)benzimidazole
2-benzimidazolecarcamic acid methyl ester
methyl 2-benzimidazolecarbamate
methyl benzimidazol-2-ylcarbamate
methyl-1H-benzimidazol-2-yl carbamate
methyl-2-benzimidazole carbamate
methyl-2-benzimidazolecarbamate
methyl-alpha-benzimidazole carbamate
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search